| Treosulfan studied in …STUDIED_INderived28 of 28show fewer |
|---|
| → studied in | NCT01949129Phase 2/Phase 3 · recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia · 28 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025824Phase 2 · recruiting Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01063647Phase 1/Phase 2 · completed Dose-range Finding Treosulfan-based Conditioning · 28 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994808Phase 2 · terminated Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · 28 trials list this drug (5 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Anaplastic Large Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534620Phase 1 · completed Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493538Phase 2 · recruiting MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases · 28 trials list this drug (5 active) | — | — | Acute Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965597Phase 2 · completed Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) · 28 trials list this drug (5 active) | — | — | Hematologic Neoplasm with Germline GATA2 Mutation,Hematologic Neoplasm with Germline SAMD9 Mutation,Hematologic Neoplasm with Germline SAMD9L Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636787Phase 2 · recruiting Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients · 28 trials list this drug (5 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03961919Phase 2 · completed Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant · 28 trials list this drug (5 active) | — | — | Transplant-Related Hematologic Malignancy,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796068Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant · 28 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00860574Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01894477Phase 2 · unknown Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822393Phase 3 · completed Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333058Phase 2 · completed Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies · 28 trials list this drug (5 active) | — | — | Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987636Phase 3 · completed Study in Localized and Disseminated Ewing Sarcoma · 28 trials list this drug (5 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02852083Phase 2 · unknown A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC · 28 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772953Phase 2 · completed Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01079013Phase 2 · unknown Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies · 28 trials list this drug (5 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00491634Phase 2 · completed Treosulfan-based Conditioning for Transplantation in AML/MDS · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00170690Phase 3 · completed Preference Study With Elderly Patients Recurrent Ovarian Cancer · 28 trials list this drug (5 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810926Phase 2 · unknown T&B Depletion Non Malignant · 28 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253513Phase 1/Phase 2 · completed Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · 28 trials list this drug (5 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01063660Phase 2 · completed Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) · 28 trials list this drug (5 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01062490Phase 2 · completed Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS) · 28 trials list this drug (5 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00598624Phase 2 · unknown Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) · 28 trials list this drug (5 active) | — | — | Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129155Phase 2 · unknown MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies · 28 trials list this drug (5 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00168870Phase 2 · unknown Study of Metastatic Ocular Melanoma · 28 trials list this drug (5 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |